Craig M. Bula - Concepedia

Author

Craig M. Bula

University of California, Riverside

Also Known As

C. M. Bula, Craig Bula, Craig M. Bula, Craig. M. Bula

Publications

717

Citations

H-Index

Concepts

All Affiliations

University of California, Riverside Teijin (Japan)

About

Craig M. Bula is an author at University of California, Riverside specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	156
2	Biochemistry	5	5	149
3	Natural Sciences	3	3	81
4	Cell Biology	2	2	75
5	Engineering	1	1	17

Craig M. Bula

Publications

542

Citations

H-Index

Page 1

	Year	Citations
Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH) <sub>2</sub> -vitamin D <sub>3</sub> signaling Mathew T. Mizwicki, Don Keidel, Craig M. Bula, Proceedings of the National Academy of Sciences	2004	159
Nongenotropic, Anti-Apoptotic Signaling of 1α,25(OH)2-Vitamin D3 and Analogs through the Ligand Binding Domain of the Vitamin D Receptor in Osteoblasts and Osteocytes Anthony Vertino, Craig M. Bula, Jin‐Ran Chen, Journal of Biological Chemistry	2005	105
Stimulation of p53 DNA Binding by c-Abl Requires the p53 C Terminus and Tetramerization Ying Nie, Heng-Hong Li, Craig M. Bula, Molecular and Cellular Biology	2000	73
Presence of a Truncated Form of the Vitamin D Receptor (VDR) in a Strain of VDR-Knockout Mice Craig M. Bula, Johanna Huhtakangas, Christopher J. Olivera, Endocrinology Knockout MouseBiochemistryMedicineVdr-knockout MiceImmunology	2005	51
25-Dehydro-1α-Hydroxyvitamin D3- 26,23S-Lactone Antagonizes the Nuclear Vitamin D Receptor by Mediating a Unique Noncovalent Conformational Change Craig M. Bula, Jill E. Bishop, Seiichi Ishizuka, Molecular Endocrinology 25-Dehydro-1α-hydroxyvitamin D3- 26,23S-lactoneMolecular PharmacologyTranscriptional RegulationBiochemistryMedicine	2000	41
On the Mechanism Underlying (23S)-25-Dehydro-1α(OH)-vitamin D3-26,23-lactone Antagonism of hVDRwt Gene Activation and Its Switch to a Superagonist Mathew T. Mizwicki, Craig M. Bula, Paween Mahinthichaichan, Journal of Biological Chemistry	2009	32
Prolactin Blocks Nuclear Translocation of VDR by Regulating Its Interaction with BRCA1 in Osteosarcoma Cells Changhui Deng, Eric Ueda, KuanHui E. Chen, Molecular Endocrinology Tumor BiologySclerostinChemoprevention StrategyCell RegulationOncogenic Agent	2008	24
New insights into Vitamin D sterol-VDR proteolysis, allostery, structure–function from the perspective of a conformational ensemble model Mathew T. Mizwicki, Craig M. Bula, June E. Bishop, The Journal of Steroid Biochemistry and Molecular Biology Protein ChemistryProtein AssemblyBiochemistryProtein FoldingNatural Sciences	2007	23
A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure–function results of A-ring modified Vitamin D sterols Mathew T. Mizwicki, Craig M. Bula, June E. Bishop, The Journal of Steroid Biochemistry and Molecular Biology EngineeringBiochemistryMedicineConformational Ensemble ModelConformational Study	2005	17
25-Dehydro-1 -Hydroxyvitamin D3- 26,23S-Lactone Antagonizes the Nuclear Vitamin D Receptor by Mediating a Unique Noncovalent Conformational Change Craig M. Bula Molecular Endocrinology Natural SciencesChromatinMolecular BiologyBiochemistry	2000	17

Page 1